Cargando…
AHR Over-Expression in Papillary Thyroid Carcinoma: Clinical and Molecular Assessments in a Series of Italian Acromegalic Patients with a Long-Term Follow-Up
AIM: Acromegaly reportedly carries an increased risk of malignant and benign thyroid tumors, with a prevalence of thyroid cancer of around 3–7%. Germline mutations in the aryl-hydrocarbon receptor (AHR) interacting protein (AIP) have been identified in familial forms of acromegaly. The molecular and...
Autores principales: | Mian, Caterina, Ceccato, Filippo, Barollo, Susi, Watutantrige-Fernando, Sara, Albiger, Nora, Regazzo, Daniela, de Lazzari, Paola, Pennelli, Gianmaria, Rotondi, Sandra, Nacamulli, Davide, Pelizzo, Maria Rosa, Jaffrain-Rea, Marie-Lise, Grimaldi, Franco, Occhi, Gianluca, Scaroni, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096503/ https://www.ncbi.nlm.nih.gov/pubmed/25019383 http://dx.doi.org/10.1371/journal.pone.0101560 |
Ejemplares similares
-
A constitutive active MAPK/ERK pathway due to BRAF(V600E) positively regulates AHR pathway in PTC
por: Occhi, Gianluca, et al.
Publicado: (2015) -
Frequency and Significance of Ras, Tert Promoter, and Braf Mutations in Cytologically Indeterminate Thyroid Nodules: A Monocentric Case Series at a Tertiary-Level Endocrinology Unit
por: Censi, Simona, et al.
Publicado: (2017) -
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma
por: Cavedon, Elisabetta, et al.
Publicado: (2017) -
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma
por: Galuppini, Francesca, et al.
Publicado: (2019) -
Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden
por: Manso, Jacopo, et al.
Publicado: (2020)